MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma

Despite better therapeutic options and improved survival of diffuse large B-cell lymphoma (DLBCL), 30–40% of the patients experience relapse or have primary refractory disease with a dismal prognosis. To identify biological correlates for treatment resistance, we profiled microRNAs (miRNAs) of match...

Descripción completa

Detalles Bibliográficos
Autores principales: Leivonen, Suvi-Katri, Icay, Katherine, Jäntti, Kirsi, Siren, Ilari, Liu, Chengyu, Alkodsi, Amjad, Cervera, Alejandra, Ludvigsen, Maja, Hamilton-Dutoit, Stephen Jacques, d’Amore, Francesco, Karjalainen-Lindsberg, Marja-Liisa, Delabie, Jan, Holte, Harald, Lehtonen, Rainer, Hautaniemi, Sampsa, Leppä, Sirpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802506/
https://www.ncbi.nlm.nih.gov/pubmed/29242506
http://dx.doi.org/10.1038/s41408-017-0033-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802506/
https://www.ncbi.nlm.nih.gov/pubmed/29242506
http://dx.doi.org/10.1038/s41408-017-0033-8

Ejemplares similares